window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : December 6, 2025

  • News
  • About Us
Contact Us

translational medicine

  • Clinical Development,Clinical Trials,Precision medicine

    BiomX’s BX004 slashes antibiotic-resistant bacteria in landmark cystic fibrosis study

    Peer-reviewed trial results demonstrate robust bacterial reduction without resistance in [...]

    July 16, 2025
  • Clinical Development,Drug Development,Precision medicine,Rare Diseases,Technology and platforms

    Rewind Therapeutics strengthens Scientific Advisory Board with leading neurology experts as it advances remyelination therapy

    Appointments enhance clinical expertise as GPR17 modulator progresses toward trials [...]

    July 2, 2025
  • Cell & Gene Therapy

    Powerhouse partnership targets faster path to gene therapies

    eXmoor Pharma and KU Leuven team up to launch CGT [...]

    May 13, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CNS Pharmaceuticals announces primary analysis of Berubicin in second line treatment of glioblastoma multiforme
    Categories: Central Nervous System, Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
  • Horiba UK launches philanthropic foundation to advance scientific research and broaden STEM participation
    Categories: Facilities and infrastructure, Healthcare leadership, Research & Development
  • Net-zero in action: ABB powers GSK’s sustainability leap in Singapore
    Categories: CDMOs & Manufacturing, Market Access & Commercialization, Sustainability
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top